Indonesia approves AstraZeneca vaccine for emergency use
- Wall Street rebounds after two-day fall; Netflix slides
- Netflix (NFLX) Plunges Following Q1 Sub Miss, But One Analyst Sees Chance to Turn Bullish
- Oil prices drop on U.S. crude build, COVID-19 surge in India
- Intuitive Surgical (ISRG) Q1 Beat Prompts Two Street Upgrades
- U.S. dollar losses bounce after Canada tips toward higher rates
Workers unload boxes of AstraZeneca vaccine against COVID-19 that arrived at the Soekarno-Hatta International Airport in Tangerang, on the outskirts of Jakarta, Indonesia, March 8, 2021. Muhammad Iqbal/Antara Foto via REUTERS
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
JAKARTA (Reuters) - Indonesia has approved AstraZeneca's COVID-19 vaccine for emergency use, Penny K. Lukito, the chief of the country's food and drug agency, told a news conference on Tuesday.
More than one million doses of the vaccine arrived late on Monday via the COVAX global vaccine-alliance scheme. About 38 million doses of a vaccine produced by China's Sinovac Biotech have arrived in the Southeast Asian country so far, some of which have been used in a mass inoculation drive starting in January.
(Reporting by Stanley Widianto; Editing by Ed Davies)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Airbus shakes up aero parts manufacturing
- New rules allowing small drones to fly over people in U.S. take effect
- Facebook tweaks ad tools ahead of Apple's privacy changes